Invention Grant
- Patent Title: Indolylmaleimide derivatives as PKC inhibitors
- Patent Title (中): 吲哚马来酰亚胺衍生物作为PKC抑制剂
-
Application No.: US10586421Application Date: 2005-01-19
-
Publication No.: US07648989B2Publication Date: 2010-01-19
- Inventor: Maurice Van Eis , Peter Von Matt , Jürgen Wagner , Jean-Pierre Evenou , Walter Schuler
- Applicant: Maurice Van Eis , Peter Von Matt , Jürgen Wagner , Jean-Pierre Evenou , Walter Schuler
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Hoxie & Associates LLC
- Agent Jay Pattumudi
- Priority: GB0401089.8 20040119; GB0401090.6 20040119
- International Application: PCT/EP2005/000502 WO 20050119
- International Announcement: WO2005/068455 WO 20050728
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/4025 ; C07D403/14
Abstract:
This invention relates to PKC inhibitors which are able to selectively inhibit e.g. the and optionally 0, isoforms of PKC, and their use in particular in transplantation.
Public/Granted literature
- US20080242675A1 Indolylmaleimide Derivatives as Pkc Inhibitors Public/Granted day:2008-10-02
Information query
IPC分类:
